RNA in-situ hybridization studies from a patient who died due to CRS after treatment with anti-CD19 CAR T cell therapy noted that both interstitial cells and vascular endothelium lining cells expressed IL-6, which was markedly elevated. This evidence concerns the gene IL6 and congenital rubella syndrome.